Industry Reports

Takeda Pharmaceutical Company Limited notes the share price movement with respect to Shire plc. Takeda confirms that it is considering making an approach to Shire regarding a possible offer for the company. Takeda’s consideration of such...

Sales up 25.5 percent to EUR 9.66 billion in fiscal year 2017 Strong volume increase in all segments EBITDA pre exceptionals up by 29.6 percent to EUR 1.29 billion EBITDA margin pre exceptionals...

TxCell SA , a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity and transplantation, announces its financial results for 2017 and its objectives for 2018. “In 2017, TxCell successfully finalized its...

Contract development and manufacturing organisation (CDMO) Ardena has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines. Originating from Organon and Merck Sharp & Dohme (MSD) in 2012, Netherlands-based ChemConnection has rapidly evolved to become...

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It is positive, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares...

Why Roche paid $1.9 billion for a 5-year-old companyEarlier this month, Roche, a global pharmaceutical giant, acquired Flatiron Health, an oncology-focused electronic health records (EHR) company, for $1.9 billion. Prior to this, Roche had a 12.6% stake in the...

Period October – December 2017 Revenues amounted to SEK 0.0 (0.3) million Operating result amounted to SEK –22.6 (–16.4) million Result after tax amounted to SEK –22.4 (–16.3) million,corresponding to SEK –0.36 per share (–0.27) before and after...